Skip to search formSkip to main contentSkip to account menu

Glutamic Acid Decarboxylase Antibody Measurement

Known as: GAD Antibody, GADAB, Glutamic Acid Decarboxylase Antibody 
The determination of the amount of glutamic acid decarboxylase antibody present in a sample.
National Institutes of Health

Related topics

Related topics

4 relations
CDISC SDTM Laboratory Test Terminology by CodeCDISC SDTM Laboratory Test Terminology by NameClinical Data Interchange Standards Consortium TerminologyGlutamic Acid Decarboxylase Antibody

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Analysis of diabetes-associated autoantibodies in children and adolescents with autoimmune thyroid diseases
Abstract Background Zinc transporter 8 autoantibodies (ZnT8Abs) together with glutamic acid decarboxylase autoantibodies (GADAbs… 
2015
2015
Comment on Liu et al. Latent Autoimmune Diabetes in Adults With Low-Titer GAD Antibodies: Similar Disease Progression With Type 2 Diabetes: A Nationwide, Multicenter Prospective Study (LADA China…
We thank Shah and Yu (1) for their comments on our study (2) and for the opportunity to discuss some key points on the GAD… 
2012
2012
Epilepsy associated with glutamic acid decarboxylase antibody (GADA)
There is increasing evidence from several case series and case reports of the clinical importance of glutamic acid decarboxylase… 
Review
2012
Review
2012
Clinical analysis of fulminant type 1 diabetes in China and comparison with a nationwide survey in Japan.
Review
2008
Review
2008
[Latent autoimmune diabetes of adult or slim type 2 diabetes mellitus?].
The prevalence of latent autoimmune diabetes of the adult (LADA) varies according to the population studied, criteria used and… 
2006
2006
[Decrease of FOXP3 mRNA in CD4+ T cells in latent autoimmune diabetes in adult].
OBJECTIVE To study the percentage of peripheral blood CD4(+)CD25(+) T cells and the expression of FOXP3 mRNA in the patients with… 
2004
2004
Seroconversion of GAD antibody in unclassified diabetes with long duration of disease.
Latent autoimmune diabetes in adults (LADA) (1), or slowly progressive insulin-dependent diabetes mellitus (SPIDDM) (2), is a… 
2000
2000
Autoimmune markers in slow type 1 diabetes: confrontation to type 1 diabetes.
UNLABELLED Slow onset type 1 diabetes is an heterogeneous entity. Its clinical features may mimick type 2 diabetes but its… 
1997
1997
Glutamate decarboxylase autoimmunity and growth hormone secretion in type I diabetes mellitus.
1994
1994
Glutamic acid decarboxylase antibodies, autonomic nerve antibodies and autonomic neuropathy in diabetic patients
SummaryTo clarify whether GAD-ab are associated with diabetic autonomic neuropathy and/or complement fixing antibodies against… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)